Abstract
AZD9291 is one of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC). Interstitial lung disease (ILD) induced by AZD9291 is very seldom. We provide a case of NSCLC treated with AZD9291 who developed ILD and died in order to improve the knowledge on AZD9291.
Author supplied keywords
Cite
CITATION STYLE
APA
Deng, S. M., Huang, J. A., & Chen, Y. B. (2018). Fatal interstitial lung disease associated with AZD9291. Journal of Cancer Research and Therapeutics, 14(12), S1227–S1229. https://doi.org/10.4103/0973-1482.199380
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free